205 related articles for article (PubMed ID: 8825366)
1. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
4. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study.
McGlone ER; Malallah K; Cuenco J; Wewer Albrechtsen NJ; Holst JJ; Vincent RP; Ling C; Khan OA; Verma S; Ahmed AR; Walters JRF; Khoo B; Bloom SR; Tan TMM
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E671-E679. PubMed ID: 33459181
[TBL] [Abstract][Full Text] [Related]
6. Enteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates.
Fricker G; Drewe J
J Pharmacol Exp Ther; 1995 Aug; 274(2):826-32. PubMed ID: 7636746
[TBL] [Abstract][Full Text] [Related]
7. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
Walker S; Rudolph G; Raedsch R; Stiehl A
Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
[TBL] [Abstract][Full Text] [Related]
8. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine.
Michael S; Thöle M; Dillmann R; Fahr A; Drewe J; Fricker G
Eur J Pharm Sci; 2000 Apr; 10(2):133-40. PubMed ID: 10727879
[TBL] [Abstract][Full Text] [Related]
9. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.
Aldini R; Roda A; Montagnani M; Cerrè C; Pellicciari R; Roda E
Steroids; 1996 Oct; 61(10):590-7. PubMed ID: 8910972
[TBL] [Abstract][Full Text] [Related]
10. Effect of bile acids on absorption of nitrendipine in healthy subjects.
Sasaki M; Maeda A; Sakamoto K; Fujimura A
Br J Clin Pharmacol; 2001 Dec; 52(6):699-701. PubMed ID: 11736882
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
[TBL] [Abstract][Full Text] [Related]
12. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
Dening TJ; Douglas JT; Hageman MJ
Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
14. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
15. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
Igimi H; Asakawa S; Watanabe D; Shimura H
Gastroenterol Jpn; 1983 Apr; 18(2):93-7. PubMed ID: 6852442
[TBL] [Abstract][Full Text] [Related]
16. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
17. Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether.
Drewe J; Fricker G; Vonderscher J; Beglinger C
Br J Pharmacol; 1993 Feb; 108(2):298-303. PubMed ID: 8448581
[TBL] [Abstract][Full Text] [Related]
18. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
19. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
Rust C; Sauter GH; Oswald M; Büttner J; Kullak-Ublick GA; Paumgartner G; Beuers U
Eur J Clin Invest; 2000 Feb; 30(2):135-9. PubMed ID: 10651838
[TBL] [Abstract][Full Text] [Related]
20. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Marschall HU; Matern H; Wietholtz H; Egestad B; Matern S; Sjövall J
J Clin Invest; 1992 Jun; 89(6):1981-7. PubMed ID: 1602004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
